- Home
- A-Z Publications
- Medicinal Chemistry
- Previous Issues
- Volume 19, Issue 3, 2023
Medicinal Chemistry - Volume 19, Issue 3, 2023
Volume 19, Issue 3, 2023
-
-
An Explicative Review on the Progress of Quinazoline Scaffold as Bioactive Agents in the Past Decade
Authors: Naman Jain, Tanvi Goel, Snehal Thakar, Madhav Jadhav and Deepali BansodeIn the last decade, quinazoline has been one of the most explored scaffolds by researchers around the globe in medicinal chemistry. Its unique structural features provide a wide range of substitutions for nitrogen and carbonyl groups. In the current situation of COVID-19, hydroxychloroquine, an antimalarial drug of the quinoline category, was used for the treatment of severe infections. Various substitution Read More
-
-
-
Design, Synthesis, and Molecular Docking Study of Novel 3-Cyanopyridine Derivatives for the Anti-Cancer Drug Target Survivin Protein
Authors: Jia-Hao Lu, Wu-Ji Lai, Li-He Jiang, Fu-Hou Lei, Li-Qun Shen and Ai-Qun WuSurvivin is an important member of the antiapoptotic protein family and controls the cell’s life cycle. Overexpression of survivin in tumor cells leads to inhibition of apoptosis, thus contributing to cancer cell proliferation. The largest binding pocket in the survivin dimer was located in the BIR domain. The key to the efficacy of 3-cyanopyridines was their surface interaction with the survivin amino acid Ile74. Methods: Through t Read More
-
-
-
Revisiting Purine Nucleoside Cholinesterase Inhibitors - An Experimental Glycon Structure/Activity Relationship Study
Background: A new family of purine nucleoside cholinesterase inhibitors was disclosed by us, with potency and selectivity over acetylcholinesterase or butyrylcholinesterase controlled by tuning structural and stereochemical features of nucleosides with perbenzylated glycosyl moieties. Objective: Design, synthesis, and biological evaluation of new purine nucleosides were used to investigate glycon protecting group pattern required Read More
-
-
-
Design, Synthesis, and Evaluation of Novel Pyruvate Dehydrogenase Kinase Inhibitors
Aims: The present work describes the synthesis and the biological evaluation of novel compounds acting as pyruvate dehydrogenase kinase (PDK) inhibitors. These drugs should become a new therapeutic approach for the treatment of pathologies improved by the control of the blood lactate level. Methods: Four series of compounds belonging to N-(4-(N-alkyl/aralkylsulfamoyl)phenyl)-2- methylpropanamides and 1,2,4-benzothi Read More
-
-
-
Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19
Authors: Lok Y. Hui, Chan Sook Mun, Lai Cong Sing, Harish Rajak, Rohini Karunakaran and Veerasamy RavichandranBackground: The severe acute respiratory syndrome coronavirus-2 is causing a disaster through coronavirus disease-19 (COVID-19), affecting the world population with a high mortality rate. Although numerous scientific efforts have been made, we do not have any specific drug for COVID-19 treatment. Objective: Aim of the present study was to analyse the molecular interaction of nitrogen heterocyclic based drugs (hydroxyc Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/mc
Journal
10
5
false
en
